To direct the Secretary of Health and Human Services to award contracts, grants, and cooperative agreements to expand and enhance manufacturing capacity of vaccines and vaccine candidates to prevent the spread of SARS-CoV-2 and COVID-19.

2/8/2022, 11:16 PM

Congressional Summary of HR 7104

This bill directs the Biomedical Advanced Research and Development Authority to award grants and enter into other transactions to increase the manufacturing of vaccines that prevent COVID-19.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 7104

Bill HR 7104 is currently in the status of Bill Introduced since June 4, 2020. Bill HR 7104 was introduced during Congress 116 and was introduced to the House on June 4, 2020. Bill HR 7104's most recent activity was Referred to the House Committee on Energy and Commerce. as of June 4, 2020

Bipartisan Support of Bill HR 7104

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 7104

Primary Policy Focus

Health

Potential Impact Areas

- Cardiovascular and respiratory health

- Congressional oversight

- Emergency medical services and trauma care

- Government employee pay, benefits, personnel management

- Government studies and investigations

- Health programs administration and funding

- Health promotion and preventive care

- Health technology, devices, supplies

- Immunology and vaccination

- Infectious and parasitic diseases

- Manufacturing

- Medical research

- Research administration and funding

- World health

Alternate Title(s) of Bill HR 7104

To direct the Secretary of Health and Human Services to award contracts, grants, and cooperative agreements to expand and enhance manufacturing capacity of vaccines and vaccine candidates to prevent the spread of SARS-CoV-2 and COVID-19.